{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:03:45Z","timestamp":1793714625152,"version":"4.6.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jaad.2021.01.012","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T08:51:19Z","timestamp":1610355079000},"page":"1339-1347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":157,"title":["Facial and neck erythema associated with dupilumab treatment: A systematic review"],"prefix":"10.1016","volume":"84","author":[{"given":"Christine E.","family":"Jo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Finstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge R.","family":"Georgakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jensen","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Drucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jaad.2021.01.012_bib1","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"issue":"10086","key":"10.1016\/j.jaad.2021.01.012_bib2","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.012_bib3","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjd.16156","volume":"178","author":"de Bruin-Weller","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jaad.2019.06.026","article-title":"Characterizing dupilumab facial redness: a multi-institution retrospective medical record review","volume":"82","author":"Waldman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2021.01.012_bib5","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1001\/jamadermatol.2019.0109","article-title":"Assessment of the development of new regional dermatoses in patients treated for atopic dermatitis with dupilumab","volume":"155","author":"Zhu","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2021.01.012_bib6","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jdcr.2019.07.020","article-title":"Dupilumab facial redness: positive effect of itraconazole","volume":"5","author":"de Beer","year":"2019","journal-title":"JAAD Case Rep"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.012_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjd.18730","article-title":"Clinical and histopathological characterization of paradoxical head and neck erythema in atopic dermatitis patients treated with dupilumab: a case series","volume":"183","author":"de Wijs","year":"2020","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2021.01.012_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jdcr.2018.08.027","article-title":"The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy","volume":"4","author":"Suresh","year":"2018","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib9","first-page":"1","article-title":"Rosacea associated with dupilumab therapy","volume":"32","author":"Heibel","year":"2019","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.012_bib10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jaad.2019.06.018","article-title":"Factors associated with patient-reported importance of skin clearance among adults with psoriasis and atopic dermatitis","volume":"81","author":"Egeberg","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.012_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","article-title":"Methodological quality and synthesis of case series and case reports","volume":"23","author":"Murad","year":"2018","journal-title":"BMJ Evid Based Med"},{"key":"10.1016\/j.jaad.2021.01.012_bib13","author":"Dalia"},{"key":"10.1016\/j.jaad.2021.01.012_bib14","first-page":"79","article-title":"Dupilumab side effect in a patient with atopic dermatitis: a case report study","volume":"13","author":"Albader","year":"2019","journal-title":"Biologics"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib15","doi-asserted-by":"crossref","first-page":"e12762","DOI":"10.1111\/dth.12762","article-title":"New alcohol flushing in a patient with atopic dermatitis under therapy with dupilumab","volume":"32","author":"Herz","year":"2019","journal-title":"Dermatol Ther"},{"issue":"11","key":"10.1016\/j.jaad.2021.01.012_bib16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/jamadermatol.2019.2613","article-title":"Development or exacerbation of head and neck dermatitis in patients treated for atopic dermatitis with dupilumab","volume":"155","author":"Soria","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.012_bib17","doi-asserted-by":"crossref","first-page":"AB4","DOI":"10.1016\/j.jaad.2019.06.056","article-title":"A case of facial erythema in a patient with atopic dermatitis treated with dupilumab","volume":"81","author":"Wang","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.012_bib18","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01676830.2018.1553190","article-title":"Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis","volume":"38","author":"Yamane","year":"2019","journal-title":"Orbit"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.012_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jdcr.2019.12.002","article-title":"Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab","volume":"6","author":"Igelman","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib20","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jaad.2019.03.020","article-title":"Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis","volume":"81","author":"Stout","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.012_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/jcm9041241","article-title":"Dupilumab for the treatment of atopic dermatitis in an Austrian cohort-real-life data shows rosacea-like folliculitis","volume":"9","author":"Quint","year":"2020","journal-title":"J Clin Med"},{"issue":"9","key":"10.1016\/j.jaad.2021.01.012_bib22","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1111\/jdv.16383","article-title":"Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports","volume":"34","author":"Okiyama","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.012_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/DER.0000000000000481","article-title":"Psoriasiform dermatitis after initiation of treatment with dupilumab for atopic dermatitis","volume":"30","author":"Fowler","year":"2019","journal-title":"Dermatitis"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.012_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jdcr.2020.01.012","article-title":"Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis","volume":"6","author":"Varma","year":"2020","journal-title":"JAAD Case Rep"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.012_bib25","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/ced.13901","article-title":"Psoriasis induced by dupilumab therapy","volume":"44","author":"Safa","year":"2019","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.012_bib26","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/DER.0000000000000509","article-title":"Psoriasis-like dermatitis developing in a patient with atopic dermatitis treated with dupilumab","volume":"30","author":"Stout","year":"2019","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.012_bib27","doi-asserted-by":"crossref","first-page":"e12998","DOI":"10.1111\/dth.12998","article-title":"A case of guttate psoriasis during treatment with dupilumab","volume":"32","author":"Gori","year":"2019","journal-title":"Dermatol Ther"},{"issue":"9","key":"10.1016\/j.jaad.2021.01.012_bib28","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of Th1\/Th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2021.01.012_bib29","first-page":"278","article-title":"Demodex musculi infestation in genetically immunomodulated mice","volume":"66","author":"Smith","year":"2016","journal-title":"Comp Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib30","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.4081\/dr.2016.6387","article-title":"Rosacea: a clinical review","volume":"8","author":"Mikkelsen","year":"2016","journal-title":"Dermatol Rep"},{"issue":"5","key":"10.1016\/j.jaad.2021.01.012_bib31","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/bjd.16330","article-title":"Could conjunctivitis in patients with atopic dermatitis treated with dupilumab be caused by colonization with Demodex and increased interleukin-17 levels?","volume":"178","author":"Thyssen","year":"2018","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2021.01.012_bib32","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1001\/archderm.140.12.1542-b","article-title":"Alcohol intolerance and facial flushing in patients treated with topical tacrolimus","volume":"140","author":"Milingou","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2021.01.012_bib33","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.omtm.2019.08.004","article-title":"Gene therapy correction of aldehyde dehydrogenase 2 deficiency","volume":"15","author":"Matsumura","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.012_bib34","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1371\/journal.pmed.1000050","article-title":"The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption","volume":"6","author":"Brooks","year":"2009","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib35","first-page":"40","article-title":"Alcohol and medication interactions","volume":"23","author":"Weathermon","year":"1999","journal-title":"Alcohol Res Health"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.012_bib36","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/cpt.1058","article-title":"Evaluation of potential disease-mediated drug-drug interaction in patients with moderate-to-severe atopic dermatitis receiving dupilumab","volume":"104","author":"Davis","year":"2018","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib37","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2018.07.043","article-title":"Dupilumab use in allergic contact dermatitis","volume":"80","author":"Machler","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.012_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DER.0000000000000414","article-title":"Dupilumab as a treatment for allergic contact dermatitis","volume":"29","author":"Chipalkatti","year":"2018","journal-title":"Dermatitis"},{"issue":"6","key":"10.1016\/j.jaad.2021.01.012_bib39","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.3390\/jcm4061217","article-title":"The role of Malassezia spp. in atopic dermatitis","volume":"4","author":"Glatz","year":"2015","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaad.2008.07.058","article-title":"The role of Malassezia in atopic dermatitis affecting the head and neck of adults","volume":"60","author":"Darabi","year":"2009","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2021.01.012_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000086438","article-title":"Head and neck atopic dermatitis and Malassezia-furfur-specific IgE antibodies","volume":"211","author":"Bayrou","year":"2005","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.012_bib42","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2019.02.002","article-title":"The skin commensal yeast Malassezia triggers a type 17 response that coordinates anti-fungal immunity and exacerbates skin inflammation","volume":"25","author":"Sparber","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaad.2021.01.012_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fcimb.2020.00112","article-title":"Malassezia-associated skin diseases, the use of diagnostics and treatment","volume":"10","author":"Saunte","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"issue":"3 Suppl","key":"10.1016\/j.jaad.2021.01.012_bib44","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaip.2015.02.009","article-title":"Contact dermatitis: a practice parameter-update 2015","volume":"3","author":"Fonacier","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.jaad.2021.01.012_bib45","first-page":"159","article-title":"Periorbital dermatitis: causes, differential diagnoses and therapy","volume":"8","author":"Feser","year":"2010","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jaad.2021.01.012_bib46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/bjd.17703","article-title":"Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials","volume":"181","author":"Blauvelt","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221000797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962221000797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:59:09Z","timestamp":1759273149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962221000797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0190962221000797"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2021.01.012","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Facial and neck erythema associated with dupilumab treatment: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2021.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}